Loading...
XHKG
3869
Market cap106mUSD
Nov 21, Last price  
6.08HKD
Name

Hospital Corporation of China Ltd

Chart & Performance

D1W1MN
XHKG:3869 chart
P/E
P/S
0.52
EPS
Div Yield, %
Shrs. gr., 5y
-7.54%
Rev. gr., 5y
28.55%
Revenues
1.44b
+1.02%
28,383,600142,524,000161,385,000149,158,000383,610,000410,883,000399,214,000520,290,0001,142,951,0001,427,733,0001,442,292,000
Net income
-39m
L
2,480,40050,935,00024,068,000-13,749,000-50,490,000150,900,000-421,069,000-362,396,000-528,597,000131,384,000-38,628,000
CFO
0k
-100.00%
3,639,6007,445,000164,039,00047,071,000122,351,00062,984,00083,485,000133,069,000143,135,00082,691,0000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hospital Corporation of China Limited, an investment holding company, engages in the operation and management of hospitals in the People's Republic of China. The company provides hospital management and consulting services to Yangsi Hospital, Cixi Hospital, and Jinhua Hospital; and general hospital services. It also engages in the wholesale of pharmaceutical products. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Hospital Corporation of China Limited is a subsidiary of Vanguard Glory Limited.
IPO date
Mar 16, 2017
Employees
1,437
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT